TREEFROG THERAPEUTICS PARTICIPATES IN AN INNOVATION SHOWCASE & POSTER SESSION AT THE INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH (ISSCR) ANNUAL MEETING
BORDEAUX, France, July 9 th , 2024 – TreeFrog Therapeutics, the French biotech company advancing a pipeline of regenerative medicine cell therapies based on a disruptive proprietary technology platform will present at several events at the global stem cell event in Hamburg, including a poster session with data from their lead program in Parkinson’s Disease and an innovation showcase with a deep dive on their transformational technology, C-Stem™.
Regenerative medicine holds immense potential in addressing some of the largest healthcare unmet needs in diseases of the major organs such as the central nervous system, the liver, pancreas and heart. However, despite major advances in the last 70 years, there are still bottlenecks holding up innovation, particularly, the ability to produce the required amount of high-quality cells, efficiently.
TreeFrog’s lead program in Parkinson’s disease has proven efficacy in pre-clinical models using a unique approach of grafting 3D format microtissues containing dopaminergic progenitors and mature dopaminergic neurons, as opposed to single-cell suspensions. The poster, presented by Maxime Feyeux, Chief Scientific Officer and Co- founder of TreeFrog will highlight the therapeutic potential of the 3D approach, and delve deeper into the characterization of the product through complementary methods including qPCR, RNAseq, flow cytometry and microscopy.
The pipeline of TreeFrog is based on their C-Stem™ technology, the culmination of over 20 years of research bringing the best in biophysics and stem cell biology together. This breakthrough technology addresses the challenges of scale and quality, and the closed system enables both the amplification and differentiation of cells. Maxime will be joined by two senior scientists – Joffrey Mianne, Head of iPSC Research and Clement Rieu, Head of Technologies R&D – during an innovation showcase about C-Stem™.
Presentations details
Poster Presentation: #190 Clinical Applications (CA) Session Wednesday, July 10, 2024 @ 6:45 PM – 7:45 PM Room: Poster & Exhibit hall Innovation Showcase Thursday July 11 th , 2024 @ 6:00PM – 6:30PM Room: Hall 3, entrance level
About TreeFrog Therapeutics
TreeFrog Therapeutics is a French-based biotech company set to unlock access to cell therapies for millions of patients. TreeFrog is unique in its approach to cell therapy development bringing together biophysicists, cell biologists and bioproduction engineers to address the challenges of the industry — producing and differentiating cells of quality at unprecedented scale, cost-effectively. To realize their mission of Cell Therapy for all, TreeFrog operates a business model that includes its own therapeutic programs and partnerships with leading biotech and industry players in other areas. In the last 3 years, the company has raised $82 million to advance a pipeline of stem cell-based therapies in regenerative medicine. In 2022, the company opened technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of the C-Stem TM platform and establish strategic alliances with leading academic, biotech and industry players.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
FunctionalAlways active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.